ArticleCancers2022

Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo.

Ioanna Savvidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.